NASDAQ:RGC | Balance Sheet | Regencell Bioscience Holdings Ltd

Complete source-backed balance-sheet history.

Available history
2018-06-30 to 2025-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2025-06-30$2.42M$2.48M$4.9M$215,434.00$5.76M$663,673.00$895,308.00$4.86M
2024-06-30$2.96M$5M$8.11M$141,734.00$8.44M$193,578.00$219,512.00$8.22M
2023-06-30$1.56M$10M$11.62M$440,829.00$12.62M$606,914.00$632,320.00$12.03M
2022-06-30$6.42M$10M$16.44M$712,594.00$18.02M$577,764.00$938,032.00$17.07M
2021-06-30$59,413.00$66,849.00$81,865.00$340,134.00$4.34M$4.34M-$4M
2020-06-30$386,979.00$386,979.00$108,321.00$514,018.00$3.16M$3.16M-$2.65M
2019-06-30$243,307.00-$1.84M
2018-06-30$153,303.00-$1.45M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.